Shigella species epidemiology and antimicrobial susceptibility: the implications of emerging azithromycin resistance for guiding treatment, guidelines and breakpoints. [electronic resource]
- The Journal of antimicrobial chemotherapy Nov 2017
- 3181-3186 p. digital
Publication Type: Journal Article
1460-2091
10.1093/jac/dkx268 doi
Adolescent Adult Aged Anti-Bacterial Agents--pharmacology Australia--epidemiology Azithromycin--pharmacology Child Child, Preschool Ciprofloxacin--pharmacology Cross-Sectional Studies Drug Resistance, Multiple, Bacterial Dysentery, Bacillary--drug therapy Female Humans Logistic Models Male Microbial Sensitivity Tests Middle Aged New South Wales--epidemiology Practice Guidelines as Topic Shigella--drug effects Young Adult